Raman Spectroscopic Analysis of Bronchoscopic Biopsy for Diagnosing Lung Cancer
Not Applicable
Not yet recruiting
- Conditions
- Lung Cancer
- Registration Number
- NCT05799027
- Lead Sponsor
- China-Japan Friendship Hospital
- Brief Summary
The goal of this clinical trial is to evaluate raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer in visible lesions in the airway. The main question it aims to answer are: the diagnostic efficacy raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer.
The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Patients who plan to undergo bronchoscopic biopsy or EBUS-TBNA
- Visible intratracheal lesions under bronchoscope
- Non-visible lesions suspected of lung cancer
Exclusion Criteria
- The patient could not tolerate further examination aimed at clarifying the cause of the disease or refused to accept further examination aimed at clarifying the cause of the disease due to poor general condition, serious organ dysfunction, etc
- The patient has no definite diagnosis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method To establish the sensitivities and specificities of Raman spectroscopic analysis of bronchoscopic biopsy for lung cancer. 7 days after the biopsy The diagnosis would be confirmed according to the pathological results.
- Secondary Outcome Measures
Name Time Method